Literature DB >> 20531198

Improvement of physical activity as an alternative objective variable to measure treatment effects of anticachexia therapy in cancer patients.

Giovanni Mantovani1, Clelia Madeddu, Roberto Serpe.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to provide an update of physical activity improvement as an alternative objective variable to measure treatment effects of anticachexia therapy in cancer patients. The assessment of physical activity level as an outcome measure for cachexia studies is attractive as it offers a patient-centered outcome concerned with functional status and independence. RECENT
FINDINGS: We present and review the most relevant recent clinical studies regarding the significance of physical activity in the context of the assessment of anticachexia treatment effects. Moreover, we have highlighted, on the basis of our recent phase III clinical trial on anticachexia treatment, the added value of correlating physical activity with the most common variables of cancer-related anorexia/cachexia syndrome.
SUMMARY: We believe that presently, and even more so in the near future, the consistent application of objective, patient-centered endpoints in cachexia trials, such as physical activity monitoring, may provide an additional significant and useful tool for the evaluation of outcomes of medical interventions in cancer cachexia.

Entities:  

Mesh:

Year:  2010        PMID: 20531198     DOI: 10.1097/SPC.0b013e32833b35c0

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  3 in total

1.  Exploring physical activity level in patients with thoracic cancer: implications for use as an outcome measure.

Authors:  Matthew Maddocks; Andrew Wilcock
Journal:  Support Care Cancer       Date:  2012-02-05       Impact factor: 3.603

Review 2.  A guide to assessing physical activity using accelerometry in cancer patients.

Authors:  J M Broderick; J Ryan; D M O'Donnell; J Hussey
Journal:  Support Care Cancer       Date:  2014-01-04       Impact factor: 3.603

3.  Scaling functional status within the interRAI suite of assessment instruments.

Authors:  John N Morris; Katherine Berg; Brant E Fries; Knight Steel; Elizabeth P Howard
Journal:  BMC Geriatr       Date:  2013-11-21       Impact factor: 3.921

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.